Thomas H. Cartwright
88 works · 14,298 citations · h-index 23
Top works
- Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
- Surgical wound healing complications in metastatic colorectal cancer patients treated with bevacizumab
- Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial
- Phase III Trial of Capecitabine Plus Oxaliplatin As Adjuvant Therapy for Stage III Colon Cancer: A Planned Safety Analysis in 1,864 Patients
- Phase II Study of Oral Capecitabine in Patients With Advanced or Metastatic Pancreatic Cancer
- Pathways, Outcomes, and Costs in Colon Cancer: Retrospective Evaluations in Two Distinct Databases
- Hyperalimentation of the cancer patient with protein-calorie undernutrition.
- Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival outcomes in stage III colon cancer and the effect of oxaliplatin on post-relapse survival: a pooled analysis of individual patient data from four randomised controlled trials
- Emergency use of uridine triacetate for the prevention and treatment of life‐threatening 5‐fluorouracil and capecitabine toxicity
- Bevacizumab does not increase bleeding in patients with metastatic colorectal cancer receiving concurrent anticoagulation
- Bevacizumab plus irinotecan/5-FU/leucovorin for treatment of metastatic colorectal cancer results in survival benefit in all pre-specified patient subgroups
- Impact of age and medical comorbidity on adjuvant treatment outcomes for stage III colon cancer: a pooled analysis of individual patient data from four randomized, controlled trials
- A randomized phase II study comparing mFOLFOX-6 combined with axitinib or bevacizumab or both in patients with metastatic colorectal cancer (mCRC).
- Treatment Decisions After Diagnosis of Metastatic Colorectal Cancer
- Wound healing/bleeding in metastatic colorectal cancer patients who undergo surgery during treatment with bevacizumab
- Effects of a Brief Multimedia Psychoeducational Intervention on the Attitudes and Interest of Patients With Cancer Regarding Clinical Trial Participation: A Multicenter Randomized Controlled Trial
- Evaluating the quality of psychosocial care in outpatient medical oncology settings using performance indicators
- Cancer of the Pancreas: Are we Making Progress? A Review of Studies in the US Oncology Research Network
- Lack of effect of bevacizumab on wound healing/bleeding complications when given 28–60 days following primary cancer surgery
- Barriers to the Access of Bevacizumab in Patients with Solid Tumors and the Potential Impact of Biosimilars: A Physician Survey